KATHERINE FARNSWORTH: Open Payments
NPI 1902436678 · MADISON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,588 in 96 payments from 21 companies in 2025. Trend: 2023 $640 · 2024 $1,550 · 2025 $2,588
Food & beverage: $2,530Education: $58
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $600 |
| ABBVIE INC. | 19 | $443 |
| UCB, Inc. | 9 | $322 |
| Regeneron Healthcare Solutions, Inc. | 4 | $199 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| GENZYME CORPORATION | 4 | $114 |
| Galderma Laboratories, L.P. | 5 | $112 |
| Amgen Inc. | 6 | $112 |
| Organon LLC | 5 | $105 |
| PFIZER INC. | 3 | $81 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, Otezla, CIBINQO.
Industry payments across CT — which companies pay providers there.
